# Comparison of Two Multimodal Analgesia Regimens in Total Knee Arthroplasty

> **NCT03990038** · NA · TERMINATED · sponsor: **Ciusss de L'Est de l'Île de Montréal** · enrollment: 2 (actual)

## Conditions studied

- Postoperative Pain

## Interventions

- **DRUG:** Continuous perineural infusion of ropivacaine 0.2% 5 ml/h for 48 h
- **DRUG:** Extended Release Capsule

## Key facts

- **NCT ID:** NCT03990038
- **Lead sponsor:** Ciusss de L'Est de l'Île de Montréal
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2019-08-01
- **Primary completion:** 2019-10-01
- **Final completion:** 2019-10-01
- **Target enrollment:** 2 (ACTUAL)
- **Why stopped:** Recruitment problems making the study completion unlikely
- **Last updated:** 2024-12-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03990038

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03990038, "Comparison of Two Multimodal Analgesia Regimens in Total Knee Arthroplasty". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03990038. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*